Twist Bioscience Director Sells $51,000 in Shares

Insider selling represents a 3.74% decrease in director's position

Apr. 3, 2026 at 8:11pm

Got story updates? Submit your updates here. ›

An extreme close-up of the intricately machined components and gears of an industrial DNA synthesis machine, conveying the advanced technology and manufacturing capabilities that power Twist Bioscience's operations.The complex inner workings of Twist Bioscience's proprietary DNA synthesis platform, which enables the company to produce genetic material at unprecedented speed and scale.South San Francisco Today

Twist Bioscience Corporation (NASDAQ:TWST) Director Melissa Starovasnik sold 1,000 shares of the company's stock on April 1, 2026 for a total transaction value of $51,000. The sale represents a 3.74% decrease in Starovasnik's ownership stake in the company.

Why it matters

Insider selling can be a signal of a director's confidence in the company's future prospects or a desire to diversify their personal holdings. This transaction provides insight into the sentiment of Twist Bioscience's leadership team.

The details

Starovasnik sold the 1,000 shares at an average price of $51 per share. Following the sale, she now directly owns 25,722 shares in the company, valued at approximately $1.31 million. The transaction was disclosed in a filing with the Securities and Exchange Commission and was executed under a pre-arranged 10b5-1 trading plan.

  • The shares were sold on Wednesday, April 1, 2026.

The players

Melissa Starovasnik

Director of Twist Bioscience Corporation.

Twist Bioscience Corporation

A synthetic biology company specializing in the development and commercialization of DNA-based products and solutions.

Got photos? Submit your photos here. ›

The takeaway

This insider sale provides a data point on the sentiment of Twist Bioscience's leadership team, though the use of a pre-arranged trading plan means the motivations behind the transaction are not entirely clear. Investors will likely continue to monitor Twist's stock performance and any future insider activity.